{
    "code": "02021576",
    "許可證字號": "衛署藥輸字第021576號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/03\/05",
    "發證日期": "86\/03\/15",
    "許可證種類": "製　劑",
    "舊證字號": "02019117",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202157601",
    "中文品名": "德壽魯素注射液２公絲／公撮",
    "英文品名": "DOXORUBICIN HYDROCHLORIDE INJECTION 2MG\/ML \"DBL\"",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟織維性肉瘤、交感神經母細胞瘤、乳癌、肺癌。",
    "劑型": "270注射劑",
    "包裝": "5、25公撮小瓶 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "DOXORUBICIN HCL",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "申請商地址": "台北市大安區敦化南路2段333號18樓",
    "主製造廠": {
        "製造廠名稱": "F020031100  HOSPIRA AUSTRALIA PTY LTD.",
        "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "(UPS)",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 P02157601德壽魯素注射液Doxorubicin-final-103-01-07.pdf 020215760001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02021576&Seq=002&Type=9"
        }
    ]
}